I trade stocks and crypto for fun, never financial advice.
Toronto
Joined September 2010
- Tweets2.7K
- Following23
- Followers216
- Likes1.1K
Taking a position in $RCT at $0.0565!
Today's PR: $7.925M insider debt-to-equity conversion at $0.25/share — a massive premium to market!
Watching for a potential AH/PM squeeze similar to $SDST before its nearly 200% run.
⚠️ Keeping a TIGHT stop loss to manage risk. High-risk, high-reward setup. Let's see if volume comes in!
$RCT #LowFloat #Nasdaq
$BKYI SHORT SQUEEZE WATCH!
Trading $3.20 with VWAP at $3.20, up 16.8% from yesterday's close!
🔥 386K shares short
🔥 20–29% short interest/float
🔥 784% reported borrow fee
🔥 ZERO shares available to borrow (tracked source)
🔥 Low-float momentum play
🔥 Fresh Middle East government cybersecurity contract catalyst
📈 Key breakout: $3.25 → $3.39 → $3.50 → $3.92
Holding VWAP could set up the next leg higher. High borrow costs + tight supply = potential squeeze pressure! 👀
$BKYI #ShortSqueeze #LowFloat #NASDAQ
$RCT trying to avoid a Nasdaq delisting? Today's PR announces a $7.925M insider debt-to-equity conversion at $0.25/share — a massive premium to market price!
Today marks Day 10 of closing below $0.10, if it finishes under that level. Is this a strategic move to regain compliance and avoid a delisting notice? 👀 #RCT #NASDAQ
$GCTK — FDA CATALYST COULD DROP ANY DAY!
✅ FDA IDE decision pending for its fully implantable continuous glucose monitoring system
✅ Fresh 1-for-2 reverse split effective Oct. 26
✅ Only ~1.18M shares outstanding post-split
✅ Estimated float ~641K (pre-latest split data)
✅ Short interest ~122K shares / 19% of estimated float (older data)
With low floats being the new theme, this should be on everyones radar. This has multiday runner written all over it.
$GCTK #LowFloat #FDA #ShortSqueeze
$SXTC could be setting up for a similar scenario to $SDST. Tomorrow marks Day 7 of closing below $0.10, approaching Nasdaq’s 10-consecutive-trading-day threshold.
Remember $SDST? It ran 170% after Day 11 passed with no immediate delisting notice.
Could history repeat itself? 👀
I’ll be loading up Monday. Watching closely! #SXTC #SDST
$SDST — I personally called Nasdaq Listing Qualifications to verify the delisting rumors. I was informed that Nasdaq has NOT issued a Staff Delisting Determination.
Reports claiming an imminent delisting are FALSE based on the information provided to me.
Do your own DD. Don't spread misinformation. $SDST
$TCRT — $350 MILLION BIOTECH DEAL BACKED BY FAIRMOUNT & PERCEPTIVE ADVISORS!
This is NOT your typical penny-stock biotech transaction.
Two major biotech investment firms with established track records are backing the newly combined company.
Here's the DD. 🧵👇
1/ FAIRMOUNT FUNDS — THE $100M LEAD INVESTOR 💰
Fairmount-affiliated funds committed approximately $100 MILLION to the $350M private placement.
Fairmount founded Paragon Therapeutics, the biotech discovery platform behind Velaris.
Look at its previous biotech deals:
🔥 $APGE — Apogee Therapeutics: Acquired by AbbVie in a transaction valued at approximately $10.9 BILLION.
🔥 $SYRE — Spyre Therapeutics: Reverse merger backed by substantial institutional financing.
🔥 $ORKA — Oruka Therapeutics: Reverse merger accompanied by approximately $275 MILLION in financing.
🔥 $JBIO — Jade Biosciences: Another Fairmount-backed biotech reverse merger.
Fairmount has a history of creating, financing and developing biotech companies.
2/ PERCEPTIVE ADVISORS — REMEMBER $DRUG?
Perceptive Advisors, led by biotech investor Joseph Edelman, is participating in the $TCRT financing.
Its track record includes:
🔥 $DRUG — Bright Minds Biosciences: Shares exploded from roughly $2 to over $38 in October 2024!
Perceptive subsequently participated in a $35M private placement at $21.70/share in November 2024 and later disclosed approximately 6.3% ownership.
🔥 Praxis Precision Medicines ($PRAX): A major biotech investment with substantial share-price appreciation in 2025.
🔥 Celcuity ($CELC): Another biotech investment that experienced a major rally in 2025.
🔥 Verona Pharma ($VRNA): Acquired by Merck in an approximately $10 BILLION transaction in 2025.
Important distinction: Perceptive's publicly announced $DRUG investment came after the October 2024 rally, not before it.
Now Perceptive is participating in the $TCRT financing alongside Fairmount and other institutional investors.
3/ LOOK AT WHO ELSE IS INVOLVED
The $350M financing includes:
▪️ Fairmount — approximately $100M commitment
▪️ Perceptive Advisors
▪️ Venrock Healthcare
▪️ Wellington Management
▪️ T. Rowe Price-advised accounts
▪️ Janus Henderson
▪️ Access Biotechnology
▪️ BB Biotech
▪️ Sirenia Capital
▪️ ADAR1 Capital
This is a substantial institutional biotech financing syndicate.
4/ WHAT DOES THE $350 MILLION DO FOR $TCRT?
$TCRT has completed its acquisition of Velaris Therapeutics, transforming the company into a clinical-development biotech focused on cardiopulmonary diseases.
The financing is expected to:
✅ Fund operations into 2029
✅ Advance its lead candidate, VLR199
✅ Support VLR360 clinical development
✅ Fund planned proof-of-concept milestones in 2028
✅ Support additional pipeline programs
✅ Strengthen the company's balance sheet
This financing provides substantial capital to advance multiple programs without immediately relying on another major equity raise.
5/ FAIRMOUNT WILL HAVE MAJOR INFLUENCE
Fairmount founding partner Peter Harwin joined the board.
Subject to shareholder approval, Fairmount representatives and designees are expected to occupy 4 of 5 board seats.
This isn't simply a passive investment.
Fairmount will have substantial influence over the company's future direction.
6/ THE BIG PICTURE — WHY $TCRT DESERVES ATTENTION 🚀
🔥 $350 MILLION institutional financing
🔥 Approximately $100M committed by Fairmount affiliates
🔥 Perceptive Advisors participating
🔥 Paragon-developed biotech pipeline
🔥 Experienced institutional syndicate
🔥 Expected funding runway into 2029
🔥 Multiple clinical-development milestones ahead
$TCRT $DRUG $APGE $SYRE $ORKA $JBIO #Biotech #NASDAQ
$ICCM $1.58 at 52 week lows is one heck of an opportunity with catalysts on the way. Low float bio with a good chance to bounce off these levels. A+ setup
$ICCM $1.60 - $1.70 = SCREAMING BUY given company is UNDERVALUED at its current low valuation. Stock should be right now between $5 - $10 range if not higher than $10+ all things considered. Purely based on cash on hand stock should be at $3+. Insiders own 51.5% of the thin float of barely 2.5 mln shares.
This DISRUPTIVE anti CANCER medical device and procedure has been winning stringent regulatory approvals across the globe with clearances in major & critical markets like USA, EU, Canada, China, Brazil, Israel, etc. These approvals demonstrate the strength & merits of IceCure's innovative ProSense cryoablation procedure to freeze tumors. Recent approval in China should give a significant boost to sales in coming years alongwith the growth in other countries where they have launced and gaining traction.
With extremely low recurrence rate IceCure's technique is seriously emerging as a better option to treat certain kinds of cancers imo.
Check their website and tweets to learn more in details. @IceCureMedical
Breast Cancer (ICE3 Trial): The 5-year local-regional recurrence or ipsilateral breast tumor recurrence (IBTR) rate is 3.1% to 4.3% (resulting in a 95.7% to 96.9% recurrence-free rate). In specialized clinical series, rates have been reported even lower (around 0.26%).
Kidney Cancer (ICESECRET Study): At a median follow-up of 4 years, the general recurrence-free rate is 83.9% (a 16.1% recurrence rate). For the subgroup of patients with unifocal tumors measuring 3 cm or smaller and no prior kidney cancer, the recurrence-free rate improves to 89.4% (a 10.6% recurrence rate)
Explosive AH moves. 0.52 and sold at 0.72. Moving my profits into $TRAW for a swing. This one has real potential. Thanks for the DD @StocksGambino
416trader retweeted
I AM OFFICIALLY RESTARTING THE $1,000 TO $1,000,000 $SPY CHALLENGE NEXT MONDAY! 💸
I’M GOING TO RESTART AND LET EVERYONE FOLLOW MY EXACT TRADES FOR COMPLETELY FREE IN A PRIVATE X GROUP CHAT! 🦅
LIKE, REPOST, & COMMENT “$1K” TO BE ADDED! ❤️🔥
YOU MUST BE FOLLOWING ME TO JOIN! ☢️
